Biotech builder ElevateBio reveals its first portfolio company: AlloVir - FierceBiotech

Biotech builder ElevateBio reveals its first portfolio company: AlloVir  FierceBiotech

A week after launching with $150 million, ElevateBio is unveiling its first portfolio company: AlloVir, a biotech working on off-the-shelf cell therapies against ...



Comments

Popular posts from this blog

Gastrointestinal (GI) cancers: After Kate Middleton's diagnosis, here's what abdominal symptoms you should look out ...

Inside the Hospital Where Damar Hamlin’s Life Was Saved - The New York Times